MD Anderson Unveils Wave of Cancer Breakthroughs From Lung Immunotherapy to Microbiome Medicine
New MD Anderson studies report a Phase 3 immunotherapy advance in EGFR-mutant lung cancer, a dual role for B7-H3 in ...
New MD Anderson studies report a Phase 3 immunotherapy advance in EGFR-mutant lung cancer, a dual role for B7-H3 in ...
A new MD Anderson study finds that pre-existing immune rejection and the intrinsic fitness of donor-derived CAR T cells determine ...
UChicago Medicine has launched a first-of-its-kind investigator-initiated clinical trial of a fully on-site manufactured T-cell receptor therapy engineered to target ...
A new study reveals that the protein GSDMB enhances anti-PD-1 immunotherapy in bladder cancer by driving Sema7a-mediated recruitment and activation ...
A new mouse study shows that gentle, non-ablative focused ultrasound delivered before radiation therapy reprograms the breast tumor microenvironment, boosting ...
A new review details how excess copper induces cuproptosis, a mitochondria-dependent form of cell death that cancer cells are uniquely ...
Children with relapsed leukemia and solid tumors increasingly survive because of a new generation of cancer immunotherapies — CAR-T cells, ...
A Japanese case report documents a remarkable sustained response to nivolumab in a patient whose stage III melanoma recurred as ...
A new review maps the rapid rise of NK cell immunotherapy for solid tumors and warns that its cardiovascular safety ...
Chronic kidney disease affects over 10% of the global population, and a new Frontiers in Nephrology research collection maps how ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine